Uncategorized
NY Fed Survey Finds Household Income Expectations Plunge Most On Record As Inflation Seen Extending Drift Lower
NY Fed Survey Finds Household Income Expectations Plunge Most On Record As Inflation Seen Extending Drift Lower
With long-term inflation expectations…

With long-term inflation expectations (those 3-Years ahead or more) peaking more than a year ago, and even shorter inflation expectations - at least according to the NY Fed Survey of consumers - now sliding after hitting a record high 6.8% in June, we have seen a marked bounce in 2Y breakevens in recent weeks, which after recently hitting the lowest level in 2 years, have risen from 2% to 2.75% largely on the back of expectations for a bounce in commodity prices...
...which is why ahead of tomorrow's CPI print - which many expect will come in hotter than expected - many were curious to see whether the latest, just released NY Fed survey, would show a continued drop in inflation expectations, or whether January would prove to be an inflection point. The answer: while median one-, and three-year-ahead inflation expectations both decreased - from 4.99% to 4.95%, and from 2.99% to 2.71% (the lowest since Oct 2020) respectively, it was 5-year inflation expectations, which the NY Fed tracks and updates only periodically, that posted a modest increase for the second month in a row, rising from 2.32% in November to 2.42% in December and then again to 2.45% in January.
As usual, the numbers were notable enough to get flagged by Fed whisperer Nick Timiraos.
New York Fed: Median inflation expectations in January remained unchanged at 5.0% at the one-year horizon, decreased by 0.2 percentage points to 2.7% at the three-year horizon, and rose 0.1 point to 2.5% at the five-year horizon https://t.co/eiB3NEA7j3 pic.twitter.com/dJIWPFYEC5
— Nick Timiraos (@NickTimiraos) February 13, 2023
Median inflation uncertainty—or the uncertainty expressed regarding future inflation outcomes—remained unchanged at the one-year horizon but increased slightly at the three- and five-year horizons.
The median home price growth expectations declined by 0.2% to 1.1% in January - the second lowest reading since May 2020 - after a modest bounce in December following a plunge since early 2022 amid surging interest rates. The decrease was more pronounced among respondents who are older than 60 and respondents who live in the Northeast. That said, expectations for any price increase appear laughable when 30Y mortgages are sticky about 6% and suggests most households expect Fed tightening to reverse in the near future (as the alternative is a housing market collapse).
At the same time, job finding expectations have remained very strong (apparently no tech workers were surveyed)...
... which was bizarre because after increasing each month since September of last year, the median expected growth in household income dropped by 1.3 percentage point to 3.3% which was the largest one-month drop in the nearly ten-year history of the series.
That said, the January reading, is only slightly below its 12-month trailing average of 3.5%, and the series remains well above its pre-pandemic levels. January’s decrease was more pronounced among respondents with no more than a high school education, respondents older than 60, and those with annual household incomes below $50k.
Adding to the gloomy household finance picture, along the drop in household income we also saw continued declines in the median household spending growth expectations, which decreased to 5.7% in January from 5.9% in December. This is the third consecutive decline in the series.
And just to make sure you are very confused, the latest survey also found that perceptions about households’ current financial situations improved in January compared to December, with more respondents reporting they are better off than a year ago; this despite a bear market in stocks, vastly higher prices and wages that have decline in real terms every single month. Yes, it's that easy to fool Americans. In contrast, year-ahead expectations about households’ financial situations deteriorated slightly, with more respondents expecting to be worse off a year from now.
Going back to the labor market, consumer optimism rebounded with the mean perceived probability of losing one’s job in the next 12 months decreased by 0.6 percentage point to 12.0%. Similarly, the mean probability of leaving one's job voluntarily in the next 12 months decreased by 0.2 percentage point to 19.1%.
Remarkably, despite the worst bear market in a generation, 35.7% of respondents, up from 34.9% last month, expect stocks to rise in the next 12 months. Then again, 38.5% expected higher stock prices one year ago: they were brutally wrong.
Looking at a broad universe of polled prices, over the next year consumers expect gasoline prices to rise 5.15% (from 4.1%); food prices to rise 9.02% (from 7.6%); medical costs to rise 9.73% (from 9.7%); the price of a college education to rise 9.29% (from 9.2%); and rent prices to rise 9.62% (from 9.6%).
So are US consumers finally coming to grips with the reality that no more stimmies are coming and that the continued price increases coupled with a decline in real wages, means less disposable income and, eventually, a recession? Alas, there is no definitive answer yet. Instead, here are the other key findings from the report:
Inflation
- Median home price growth expectations declined by 0.2 percentage point to 1.1% in January, the second lowest reading since May 2020. The decrease was more pronounced among respondents who are older than 60 and respondents who live in the Northeast.
- Median year-ahead expected price changes increased by 1.0 percentage point for gas (to 5.1%), 1.4 percentage point for food (to 9.0%), and 0.1 percentage point for the cost of college education (to 9.3%). The median expected change in the cost of rent and medical care remained unchanged at 9.6% and 9.7%, respectively.
Labor Market
- Median one-year-ahead expected earnings growth remained unchanged at 3.0% in January. The series has been moving between a narrow range of 2.8% to 3.0% since September 2021.
- Mean unemployment expectations—or the mean probability that the U.S. unemployment rate will be higher one year from now—increased by 0.4 percentage point to 41.2%. The increase was most pronounced for respondents with a college education and those with annual household incomes above $100k.
- The mean perceived probability of losing one’s job in the next 12 months decreased by 0.6 percentage point to 12.0%. Similarly, the mean probability of leaving one's job voluntarily in the next 12 months decreased by 0.2 percentage point to 19.1%.
- The mean perceived probability of finding a job (if one’s current job was lost) increased by 0.1 percentage point to 57.6% in January.
Household Finance
- Median household spending growth expectations decreased to 5.7% in January from 5.9% in December. This is the third consecutive decline in the series.
- Perceptions of credit access compared to a year ago improved in January, with the share of households reporting it is easier to obtain credit than one year ago increasing. Similarly, respondents were more optimistic about future credit availability, with the share of households expecting it will be easier to obtain credit a year from now also increasing.
- The average perceived probability of missing a minimum debt payment over the next three months increased to 12.1% in January from 11.4% in December.
- The median expectation regarding a year-ahead change in taxes (at current income level) increased by 0.3 percentage point to 4.4%.
- Median year-ahead expected growth in government debt increased by 0.1 percentage point to 10.2%.
- The mean perceived probability that the average interest rate on saving accounts will be higher in 12 months increased by 0.2 percentage point to 32.1%.
- Perceptions about households’ current financial situations improved in January compared to December, with more respondents reporting they are better off than a year ago. In contrast, year-ahead expectations about households’ financial situations deteriorated slightly, with more respondents expecting to be worse off a year from now.
- The mean perceived probability that U.S. stock prices will be higher 12 months from now increased by 0.8 percentage point to 35.7%.
More in the full NY Fed survey which can be found here.
Uncategorized
MBA: Mortgage Applications Decreased in Weekly Survey; Purchase Apps Lowest Since 1995
From the MBA: Mortgage Applications Decrease in Latest MBA Weekly Survey
Mortgage applications decreased 6.0 percent from one
week earlier, according to data from the Mortgage Bankers Association’s (MBA) Weekly Mortgage
Applications Survey for the we…

Mortgage applications decreased 6.0 percent from one week earlier, according to data from the Mortgage Bankers Association’s (MBA) Weekly Mortgage Applications Survey for the week ending September 29, 2023.Click on graph for larger image.
The Market Composite Index, a measure of mortgage loan application volume, decreased 6.0 percent on a seasonally adjusted basis from one week earlier. On an unadjusted basis, the Index decreased 6 percent compared with the previous week. The Refinance Index decreased 7 percent from the previous week and was 11 percent lower than the same week one year ago. The seasonally adjusted Purchase Index decreased 6 percent from one week earlier. The unadjusted Purchase Index decreased 6 percent compared with the previous week and was 22 percent lower than the same week one year ago.
“Mortgage rates continued to move higher last week as markets digested the recent upswing in Treasury yields. Rates for all mortgage products increased, with the 30-year fixed mortgage rate increasing for the fourth consecutive week to 7.53 percent – the highest rate since 2000,” said Joel Kan, MBA’s Vice President and Deputy Chief Economist. “As a result, mortgage applications ground to a halt, dropping to the lowest level since 1996. The purchase market slowed to the lowest level of activity since 1995, as the rapid rise in rates pushed an increasing number of potential homebuyers out of the market. ARM loan applications picked up over the week and the ARM share increased to 8 percent, as some borrowers searched for ways to lower their payments.”
...
The average contract interest rate for 30-year fixed-rate mortgages with conforming loan balances ($726,200 or less) increased to 7.53 percent from 7.41 percent, with points increasing to 0.80 from 0.71 (including the origination fee) for 80 percent loan-to-value ratio (LTV) loans.
emphasis added
The first graph shows the MBA mortgage purchase index.
According to the MBA, purchase activity is down 22% year-over-year unadjusted.

Uncategorized
US Median Q3 GDP Nowcast Holds Above 3%
Rising interest rates may threaten the “soft landing” outlook for the US economy, but the upcoming preliminary estimate of third-quarter GDP from the…

Rising interest rates may threaten the “soft landing” outlook for the US economy, but the upcoming preliminary estimate of third-quarter GDP from the government still looks set to report that output picked up from Q2.
The median nowcast for GDP via several sources compiled by CapitalSpectator.com indicates growth at 3.2% for the July-through-September period (seasonally adjusted annual rate). That’s substantially up from the 2.1% advance in Q2.
But in a sign of what may be brewing, today’s revised Q3 nowcast is fractionally below the previous update. It’s reasonable to assume that more downside revisions are likely ahead of the Oct. 26, when the Bureau of Economic Analysis will publish its Q3 report for GDP. One factor weighing on the outlook for the remaining Q3 nowcasts: rising Treasury yields.
The recent runup in the 10-year yield lifted the benchmark rate to 4.81% on Tuesday (Oct. 3), the highest since 2007. “I think we’re gonna go to five [percent]” for the 10-year yield, predicts former Pimco bond fund manager Bill Gross.
Upside momentum for the 10-year yield is certainly strong lately. The 50-day average for the rate, after briefly falling below its 200-day counterpart in the spring, has recently rebounded, which implies that the market will continue to reprice this yield higher in the near term.

Meanwhile, Fed officials are signaling that interest rate cuts aren’t on the horizon. In fact, it’s premature to rule out another rate hike, advises Cleveland Fed President Loretta Mester. On Monday she said: “At this point, I suspect we may well need to raise the fed funds rate once more this year and then hold it there for some time as we accumulate more information on economic developments and assess the effects of the tightening in financial conditions that has already occurred,”
Jim Bianco, president of Bianco Research, tells CNBC: “I don’t think we’re near the end of this move in the bond market.”
Higher interest rates are a new headwind for the economy in Q4 and beyond. There’s also a risk that today’s 3%-plus nowcast for the upcoming Q3 report will be revised down ahead of the Oct. 26 release. Given the recent persistence in higher nowcasts vs. Q2, however, it’s likely that growth will match or exceed the previous quarter. But the longer that interest rates rise and/or hold on to current levels, the stronger the case for revising current growth estimates down for Q4.
How is recession risk evolving? Monitor the outlook with a subscription to:
The US Business Cycle Risk Report
recession fed recession gdp interest rates
Uncategorized
Lilly’s diabetes and obesity leader to retire in broader leadership shuffle
As Eli Lilly anticipates an FDA weight-loss approval for its in-demand diabetes drug Mounjaro by year’s end, the drugmaker’s leader of those two areas…

As Eli Lilly anticipates an FDA weight-loss approval for its in-demand diabetes drug Mounjaro by year’s end, the drugmaker’s leader of those two areas will retire and be replaced by its immunology head.
Mike Mason, president of Lilly Diabetes and Obesity, will depart at the end of December after a 34-year career at the Indianapolis-based Big Pharma, per a Wednesday morning announcement. Lilly USA president and immunology president Patrik Jonsson, another three-decade veteran of the company, will take Mason’s place on Jan. 1.
Meanwhile, one of the drugmaker’s key decision makers is being handed additional duties. Science chief Daniel Skovronsky, who joined in 2010 via Lilly’s acquisition of his company Avid Radiopharmaceuticals, will take over Jonsson’s immunology role, which entails overseeing commercial and Phase III medicines in dermatology, gastroenterology and rheumatology. The company has received two complete response letters from the FDA in this area in 2023: the eczema drug lebrikizumab and ulcerative colitis drug mirikizumab. Both cited manufacturing issues as the reason.
And the C-suite will gain a chief medical officer as David Hyman expands his remit from a focus on oncology by way of Lilly’s $8 billion acquisition of Loxo Oncology in 2019. Chief consumer experience officer Jennifer Oleksiw will become global chief customer officer. The company also recruited Mark Genovese from an SVP role at Gilead Sciences to become its SVP of immunology development. Lilly’s EVP of corporate affairs and communications, Leigh Ann Pusey, is departing at the end of 2023.
“As we embark on this exciting new chapter of growth for our company, I’ve never been more confident about our ability to deliver life-changing medicines to the patients who need them,” Lilly CEO David Ricks said in a statement.
fda-
Uncategorized16 hours ago
Cardano stablecoin project gambled away investors’ money before rug: Report
-
International21 hours ago
Airlines are being hit by anti-greenwashing litigation – here’s what makes them perfect targets
-
International18 hours ago
Computer model predicts who needs lung cancer screening
-
International13 hours ago
New robot could help diagnose breast cancer early
-
Government23 hours ago
Nationwide test of Wireless Emergency Alert system could test people’s patience – or help rebuild public trust in the system
-
Uncategorized11 hours ago
SEC asks judge to reject Coinbase’s motion to dismiss lawsuit
-
Uncategorized24 hours ago
Amicus Therapeutics strikes $430m strategic financing deal
-
International22 hours ago
Exscientia ends cancer study as it focuses on other trials of AI-driven drug candidates